Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Tissue Kallikrein - Bradykinin System Targeting the Protection of Neurovascular Units in Ischemic Areas of Stroke

NCT06422572 is registered in ClinicalTrials.gov with Qin Zhang as lead sponsor.

NCT NCT06422572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06422572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Tissue Kallikrein - Bradykinin System Targeting the Protection of Neurovascular Units in Ischemic Areas of Stroke
Lead sponsor
Qin Zhang
Phase
Observational
Overall status
Completed
Start date
May 1, 2023
Completion date
December 30, 2023
Enrollment
8,602 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, ischemic